Inventor · disambiguated record
Carsten Schultz-Fademrecht
Also filed as: SCHULTZ-FADEMRECHT CARSTEN
15 granted patents·8 pending applications·162 citations·filing 2006–2022
91Inventor score
Files withJONES PHILIP3LEAD DISCOVERY CENTER GMBH3ANGELETTI P IST RICHERCHE BIO2JANSSEN PHARMACEUTICA NV2Lücking Ulrich2
Top patents by PatentIndex Score
23 records- 0196US8071623B2Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitorsJONES PHILIP·Filed 2008·Granted Dec 6, 2011·85 cites·9 claims
- 0290US8188084B2Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP)JONES PHILIP·Filed 2007·Granted May 29, 2012·24 cites·2 claims
- 0385US7799825B2Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitorsANGELETTI P IST RICHERCHE BIO·Filed 2007·Granted Sep 21, 2010·9 cites·10 claims
- 0483US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 0583US8394786B2Quinazoline derivativesFREYNE EDDY JEAN EDGARD·Filed 2009·Granted Mar 12, 2013·5 cites·8 claims
- 0683US8268827B2Pyridazinone derivatives as PARP inhibitorsBRANCA DANILA·Filed 2008·Granted Sep 18, 2012·13 cites·12 claims
- 0779US9096608B2Pharmaceutically active pyrazolo-triazine derivativesLEAD DISCOVERY CENTER GMBH·Filed 2013·Granted Aug 4, 2015·6 cites·5 claims
- 0879US8999982B2Pharmaceutically active compounds as Axl inhibitorsSCHULTZ-FADEMRECHT CARSTEN·Filed 2011·Granted Apr 7, 2015·10 cites·15 claims
- 0975US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 1069US9481668B2Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1MERCK PATENT GMBH·Filed 2014·Granted Nov 1, 2016·1 cites·3 claims
- 1168US8026265B2Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitorsISTITUTO DE RICERCHE DI BIOLOG MOLECOLARE P ANGELETTI SPA·Filed 2006·Granted Sep 27, 2011·2 cites·7 claims
- 1260US8772286B2MK2 inhibitorsBARF TJEERD ANDRIES·Filed 2010·Granted Jul 8, 2014·1 cites·16 claims
- 1358US9273013B2Quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 1, 2016·0 cites·1 claims
- 1458US2024294522A13-substituted 1h-pyrrolo[2,3-b]pyridine as grk5 modulatorsLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 1553US2016207938A1Quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 1652US2009275619A1Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) InhibitorsBOUERES Julia·Filed 2007·Application pending·0 cites
- 1748US9962389B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupBAYER IP GMBH·Filed 2017·Granted May 8, 2018·0 cites·15 claims
- 1846US2010152180A14-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)JONES PHILIP·Filed 2007·Application pending·0 cites
- 1945US2011201657A1Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitorsANGELETTI P IST RICHERCHE BIO·Filed 2011·Application pending·0 cites
- 2044US2016159800A1Mk2 inhibitorsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 2144US2022370440A14-substituted pyrrolo[2,3-b]pyridine as erbb modulators useful for treating cancerLEAD DISCOVERY CENTER GMBH·Filed 2019·Application pending·0 cites
- 2236US2013079345A1Pharmaceutically active disubstituted triazine derivativesEICKHOFF JAN·Filed 2011·Application pending·0 cites
- 2329US10934274B2Quinoline derivatives as TAM RTK inhibitorsQURIENT CO LTD·Filed 2016·Granted Mar 2, 2021·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →